According
to IMARC Group’s latest report, titled “Virtual Clinical Trials Market:
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”,
The global virtual clinical trials market
grew at a CAGR of around 7% during 2015-2020.
Virtual clinical trials (VCT) refer to the clinical tests that are conducted
remotely using advanced technological solutions. These virtual trials involve
the use of smartphone applications and electronic monitoring devices to
diagnose, detect and prevent diseases, along with several web-based platforms
to recruit, counsel, measure endpoints and obtain data from the subjects. They
also help in generating data regarding the efficiency, effectiveness, and
safety of drugs and medical procedures. Compared to the traditional clinical
trials, VCTs are less time-consuming, ensure real-time data acquisition and are
not affected by delays in patient recruitment as they can be conducted at-home
or at remote locations.
Request for a PDF sample of this
report: https://www.imarcgroup.com/virtual-clinical-trials-market/requestsample
The rising digitization of the healthcare infrastructures
is primarily driving the growth of the market. Besides this, as coronavirus
disease continues to spread across the world, there has been a considerable
increase in the demand for virtual and remote testing solutions for safe and
effective data collection. Furthermore, numerous technological innovations,
such as the introduction of virtual patient interaction platforms and the
utilization of wearable devices, are acting as other growth-inducing factors.
These technologies assist in connecting patients with treating physicians
through telemedicine platforms and obtaining e-consent for the trials, thus
strengthening the market growth. Additionally, the growing adoption of
cloud-based, web-hosted and open-source licensing delivery models is anticipated
to further propel the market in the coming years. Looking forward, IMARC Group expects the
global virtual clinical trials market to exhibit moderate growth during the
next five years.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
·
Clinical Ink Inc.
·
Covance Inc.
·
ICON Plc, IQVIA Inc.
·
LEO Innovation Lab
·
Medable Inc.
·
Medidata Solutions Inc. (Dassault Systèmes SE)
·
Medpace Holdings Inc.
·
Oracle Corporation
·
Parexel International Corporation
·
PRA Health Sciences
·
Signant Health.
Market Segmentation:
Breakup by Study Design:
·
Interventional
·
Observational
· Expanded Access
Breakup by Indication:
·
Oncology
·
Cardiovascular
·
Others
· North America (United States, Canada)
· Europe (Germany, France, United Kingdom, Italy,
Spain, Others)
· Asia Pacific (China, Japan, India, Australia,
Indonesia, Korea, Others)
· Latin America (Brazil, Mexico, Others)
· Middle East and Africa (United Arab Emirates, Saudi
Arabia, Qatar, Iraq, Others)
Ask
Analyst for Customization and Explore full report with TOC & List of
Figures: https://www.imarcgroup.com/virtual-clinical-trials-market
We are updating our reports, If you
want latest primary and secondary data (2021-2026) with Cost Module, Business
Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
United States Minimally Invasive Surgery
Market: https://www.imarcgroup.com/united-states-minimally-invasive-surgery-market
GCC Minimally Invasive Surgery Market: https://www.imarcgroup.com/gcc-minimally-invasive-surgery-market
Regulatory Affairs Outsourcing Market: https://www.imarcgroup.com/regulatory-affairs-outsourcing-market
Multiple Sclerosis Therapies Market: https://www.imarcgroup.com/multiple-sclerosis-therapies-market
Dental Implants Market: https://www.imarcgroup.com/dental-implants-market
Healthcare It Market: https://www.imarcgroup.com/healthcare-it-market
Blood Pressure Monitoring Devices Market: https://www.imarcgroup.com/blood-pressure-monitoring-devices-market
Home Fitness Equipment Market: https://www.imarcgroup.com/home-fitness-equipment-market
Repiratory Care Devices Market: https://www.imarcgroup.com/respiratory-care-devices-market
High-performance Liquid Chromatography Market: https://www.imarcgroup.com/high-performance-liquid-chromatography-market
H1n1 Vaccines Market: https://www.imarcgroup.com/h1n1-vaccines-market
IMARC’s information
products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high
technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

No comments:
Post a Comment